DEYCX
Price
$14.09
Change
+$0.03 (+0.21%)
Updated
Dec 3 closing price
Net Assets
164.31M
VTSMX
Price
$163.76
Change
+$0.68 (+0.42%)
Updated
Dec 3 closing price
Net Assets
2.05T
Interact to see
Advertisement

DEYCX vs VTSMX

Header iconDEYCX vs VTSMX Comparison
Open Charts DEYCX vs VTSMXBanner chart's image
BNY Mellon Large Cap Equity C
Price$14.09
Change+$0.03 (+0.21%)
VolumeN/A
Net Assets164.31M
Vanguard Total Stock Mkt Idx I
Price$163.76
Change+$0.68 (+0.42%)
VolumeN/A
Net Assets2.05T
DEYCX vs VTSMX Comparison Chart in %
View a ticker or compare two or three
VS
DEYCX vs. VTSMX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DEYCX is a StrongBuy and VTSMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 2.05T vs. DEYCX (164M). VTSMX pays higher dividends than DEYCX: VTSMX (1.02) vs DEYCX (0.00). DEYCX was incepted earlier than VTSMX: DEYCX (17 years) vs VTSMX (34 years). DEYCX (2.08) is less costly to investors than VTSMX (0.14). DEYCX is a more actively managed with annual turnover of: 39.80 vs. VTSMX (2.00). DEYCX has a lower initial minimum investment than VTSMX: DEYCX (1000) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 11.43 vs. DEYCX (-17.67). VTSMX return over 5 years is better than : 77.17 vs. DEYCX (-41.60).
DEYCXVTSMXDEYCX / VTSMX
Total Expense Ratio1.750.141,250%
Annual Report Gross Expense Ratio2.080.141,486%
Fund Existence17 years34 years-
Gain YTD13.13515.48985%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets164M2.05T0%
Annual Yield % from dividends0.001.02-
Returns for 1 year-17.6711.43-155%
Returns for 3 years-29.0264.40-45%
Returns for 5 years-41.6077.17-54%
Returns for 10 years-17.45223.01-8%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBBCX6.74N/A
N/A
AB Relative Value C
VNVCX22.41N/A
N/A
Natixis Vaughan Nelson Mid Cap C
BHSRX65.39N/A
N/A
BlackRock Health Sciences Opps R
AWIIX16.64N/A
N/A
CIBC Atlas Income Opportunities Instl
ESAGX13.63N/A
N/A
Ashmore Emerging Markets Equity ESG A